Mitterbauer, G <br/><br/>
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction.  [electronic resource] 

 -  British journal of haematology  Sep 1999 
 - 634-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2141.1999.01605.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Female<br/>Genes, abl--genetics<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual--diagnosis<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--diagnosis<br/>RNA, Messenger--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>Sensitivity and Specificity